IPO Letter to U.S. Senate Opposing S. 2658, the Medication Affordability and Patent Integrity Act
IPO Letter to U.S. Senate Opposing S. 2658, the Medication [...]
2025 Top 300 Patent Owners
2025 Top 300 Patent Owners
IPO Comments to USPTO Regarding the WIPO Riyadh Design Law Treaty
IPO Comments to USPTO Regarding the WIPO Riyadh Design Law [...]
IPO Comments to CNIPA Regarding Administrative Adjudication and Mediation of Patent Disputes
IPO Comments to CNIPA Regarding Administrative Adjudication and Mediation of [...]
Letter to U.S. House Committee on the Judiciary Regarding Hearing on the ETHIC Act and Skinny Labels, Big Savings Act
Letter to U.S. House Committee on the Judiciary Regarding Hearing [...]
IPO Comments on USPTO Supplemental Guidance Related to Design Patent Applications for Computer-Generated Interfaces and Icons
IPO Comments on USPTO Supplemental Guidance Related to Design Patent [...]
Resolution on Legislative Amendment to Anti-Cybersquatting Consumer Protection Act
RESOLVED, that IPO urges Congress to resolve the dispute among [...]
Resolution on Patent Subject Matter Eligibility
RESOLVED, that patent subject matter eligibility under 35 U.S.C. § 101 should [...]
IPO’s Request to the National Data Administration for an Extension of Time re: Comments on the “Guidelines for Data Property Rights Registration (Trial)”
IPO’s Request to the National Data Administration for an Extension [...]
Debunking Biopharmaceutical Patent Myths: An Evidence-Based Analysis
Debunking Biopharmaceutical Patent Myths: An Evidence-Based Analysis